In my case I gave two sets of facts in support of my argument that FCSC will (or may) be selling at below cost.
1) The London experience where the exact same product was sold for 3 years (at full capacity the last year). Losses were heavy.
2) Comparison to Provenge (the only other individualized biologic I know of). Provenge is costing about $20k to make, and per the FDA is a relatively simple process other than the individualized nature.
In response to this, you attacked me and not the argument.
Would you like to post facts to support your position, or should you ban yourself :-)
News 
Market Data 
Discover 
